Influence of metronidazole on the hypoglycaemic effect of tolbutamide in healthy albino rabbits

Indian Drugs

Volumn 40, Issue 9, 2003, Pages 535-538

  Rambhimaiah, S ^a   Suresh, D K ^b   Gupta, V R M ^b   Bheemachari, ^b   Ravi, Prakash P ^b   Srinivas, Rao P ^b  

^a M R MEDICAL COLLEGE   (India)

^b NONE

Author keywords

Drug interaction; Enzyme inhibition; Hypoglycaemia; Metronidazole; Tolbutamide

Indexed keywords

EID: 77952440408     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yuan R, Parmelee T, Balian J D, Uppoor R S, Ajayi F, Burnett A, Lejko L J and Morroum P. In Vitro interaction studies: experience of the food and drug administration. Clinicalpharmacol. There.1999., 66: 9-15.
2. th edition, published by Mcgraw-Hill, New York 1996., p 51.
3. Editorial. Coronary heart diseases in patients with diabetes. N Engl J Med 2000; 342: 1040-1042
4. Ritz E and Orth S R. Nephropathy in patients with Type 2 diabetes mellitus. N Engl J Med 1999; 341:1127-1133
5. Merimee T J. Diabetic retinopathy : A synthesis of perspectives. N Engl J Med 1990; 322: 978-983
6. Joshi N, Caputo G M, Weitekamp M R and Karchmer A W. Primary care: Infections in with diabetes mellitus. N Engl J Med 1999; 341:1906-1912
7. Murphy D P, Tan J S and File T M J. Infectious complications in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912
8. O'Reilly R A. Stereoselect interaction of warfarin and metronidazole in man. New Engl. J.Med. 1976., 295, 354-357.
9. Kazmier F J. A significant interaction between metronidazole and warfarin. Mayco Clin. Proc, 1976., 51, 782.
10. Rothstein E and Clancy D D. Toxicity of disulfiram combined with Metronidazole, New Engl. J. Med. 1969., 280, 1006.
11. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann.Clin.Biochem. 1969., 6:24-27
12. Badyal D K and Dadhich A P. Cytochrome P450 and drug interactions. Indian. J. Pharmacol. 2001, 33:248-259
13. Singh D, Vijayavargiya R, Mehta P and Kakrani A L. Tolbutamide ä frequently used drug, predominantly metabolised by hepatic microsomal enzymes, Ind. J.Pharmacol. 1980, 12 (1), 27-30.
14. Solomon H M and Schrogie J J V. Effect of Phenyramidol and bishydroxy Coumarin on the metabolism of tolbutamide in human subjects Metabolism. 1967, 16, 1029.
15. Ferrari C, Frezzati S., Testori G.P. and Bertazzoni A. Potentiation of hypoglycemic response to intravenous tolbutamide by Clofibrate, New Engl.J.Med. 1976., 294, 1184.
16. Rettie A E, Korzekwa K R, Kunze K L, Lawrence R F, Eddy A C, and Aoyama T Hydroxylation of warfarin by human cDNA-expressed cytochrome P450: a role of P450 2C9 in the etiology of (S)-warfarin drug interactions. Chem Res Toxicol. 1992, 5:54-9